389 related articles for article (PubMed ID: 18079965)
1. Vascular and inflammatory stresses mediate atherosclerosis via RAGE and its ligands in apoE-/- mice.
Harja E; Bu DX; Hudson BI; Chang JS; Shen X; Hallam K; Kalea AZ; Lu Y; Rosario RH; Oruganti S; Nikolla Z; Belov D; Lalla E; Ramasamy R; Yan SF; Schmidt AM
J Clin Invest; 2008 Jan; 118(1):183-94. PubMed ID: 18079965
[TBL] [Abstract][Full Text] [Related]
2. Simvastatin suppresses vascular inflammation and atherosclerosis in ApoE(-/-) mice by downregulating the HMGB1-RAGE axis.
Liu M; Yu Y; Jiang H; Zhang L; Zhang PP; Yu P; Jia JG; Chen RZ; Zou YZ; Ge JB
Acta Pharmacol Sin; 2013 Jun; 34(6):830-6. PubMed ID: 23564080
[TBL] [Abstract][Full Text] [Related]
3. RAGE and cardiovascular disease.
Park S; Yoon SJ; Tae HJ; Shim CY
Front Biosci (Landmark Ed); 2011 Jan; 16(2):486-97. PubMed ID: 21196183
[TBL] [Abstract][Full Text] [Related]
4. Signaling of Serum Amyloid A Through Receptor for Advanced Glycation End Products as a Possible Mechanism for Uremia-Related Atherosclerosis.
Belmokhtar K; Robert T; Ortillon J; Braconnier A; Vuiblet V; Boulagnon-Rombi C; Diebold MD; Pietrement C; Schmidt AM; Rieu P; Touré F
Arterioscler Thromb Vasc Biol; 2016 May; 36(5):800-9. PubMed ID: 26988587
[TBL] [Abstract][Full Text] [Related]
5. Receptor for AGE (RAGE) and its ligands-cast into leading roles in diabetes and the inflammatory response.
Yan SF; Ramasamy R; Schmidt AM
J Mol Med (Berl); 2009 Mar; 87(3):235-47. PubMed ID: 19189073
[TBL] [Abstract][Full Text] [Related]
6. Unlocking the biology of RAGE in diabetic microvascular complications.
Manigrasso MB; Juranek J; Ramasamy R; Schmidt AM
Trends Endocrinol Metab; 2014 Jan; 25(1):15-22. PubMed ID: 24011512
[TBL] [Abstract][Full Text] [Related]
7. Receptor for advanced glycation end products (RAGE) deficiency attenuates the development of atherosclerosis in diabetes.
Soro-Paavonen A; Watson AM; Li J; Paavonen K; Koitka A; Calkin AC; Barit D; Coughlan MT; Drew BG; Lancaster GI; Thomas M; Forbes JM; Nawroth PP; Bierhaus A; Cooper ME; Jandeleit-Dahm KA
Diabetes; 2008 Sep; 57(9):2461-9. PubMed ID: 18511846
[TBL] [Abstract][Full Text] [Related]
8. The biology of the receptor for advanced glycation end products and its ligands.
Schmidt AM; Yan SD; Yan SF; Stern DM
Biochim Biophys Acta; 2000 Dec; 1498(2-3):99-111. PubMed ID: 11108954
[TBL] [Abstract][Full Text] [Related]
9. RAGE and its ligands: a lasting memory in diabetic complications?
Yan SF; Ramasamy R; Bucciarelli LG; Wendt T; Lee LK; Hudson BI; Stern DM; Lalla E; DU Yan S; Rong LL; Naka Y; Schmidt AM
Diab Vasc Dis Res; 2004 May; 1(1):10-20. PubMed ID: 16305050
[TBL] [Abstract][Full Text] [Related]
10. Receptor for advanced glycation endproducts (RAGE) and vascular inflammation: insights into the pathogenesis of macrovascular complications in diabetes.
Wendt T; Bucciarelli L; Qu W; Lu Y; Yan SF; Stern DM; Schmidt AM
Curr Atheroscler Rep; 2002 May; 4(3):228-37. PubMed ID: 11931721
[TBL] [Abstract][Full Text] [Related]
11. SMTP-44D Inhibits Atherosclerotic Plaque Formation in Apolipoprotein-E Null Mice Partly by Suppressing the AGEs-RAGE Axis.
Terasaki M; Shibata K; Mori Y; Saito T; Matsui T; Ohara M; Fukui T; Hasumi K; Higashimoto Y; Nobe K; Yamagishi SI
Int J Mol Sci; 2023 Mar; 24(7):. PubMed ID: 37047475
[TBL] [Abstract][Full Text] [Related]
12. Receptor for advanced glycation endproducts and atherosclerosis: From basic mechanisms to clinical implications.
Basta G
Atherosclerosis; 2008 Jan; 196(1):9-21. PubMed ID: 17826783
[TBL] [Abstract][Full Text] [Related]
13. Deletion of bone marrow-derived receptor for advanced glycation end products inhibits atherosclerotic plaque progression.
Morris-Rosenfeld S; Blessing E; Preusch MR; Albrecht C; Bierhaus A; Andrassy M; Nawroth PP; Rosenfeld ME; Katus HA; Bea F
Eur J Clin Invest; 2011 Nov; 41(11):1164-71. PubMed ID: 21418204
[TBL] [Abstract][Full Text] [Related]
14. Low anticoagulant heparin targets multiple sites of inflammation, suppresses heparin-induced thrombocytopenia, and inhibits interaction of RAGE with its ligands.
Rao NV; Argyle B; Xu X; Reynolds PR; Walenga JM; Prechel M; Prestwich GD; MacArthur RB; Walters BB; Hoidal JR; Kennedy TP
Am J Physiol Cell Physiol; 2010 Jul; 299(1):C97-110. PubMed ID: 20375277
[TBL] [Abstract][Full Text] [Related]
15. Activation of the High Mobility Group Box 1/Receptor for Advanced Glycation Endproducts /NOD-like Receptor Family Pyrin Domain-Containing 3 Axis Under Chronic Intermittent Hypoxia Induction Promotes the Progression of Atherosclerosis in ApoE
Tan H; Hu J; Zuo W; Huang Y; Cui J; Gong F; Bai W
J Am Heart Assoc; 2023 Apr; 12(8):e024397. PubMed ID: 37026550
[TBL] [Abstract][Full Text] [Related]
16. Receptor for advanced glycation end products and its ligand high-mobility group box-1 mediate allergic airway sensitization and airway inflammation.
Ullah MA; Loh Z; Gan WJ; Zhang V; Yang H; Li JH; Yamamoto Y; Schmidt AM; Armour CL; Hughes JM; Phipps S; Sukkar MB
J Allergy Clin Immunol; 2014 Aug; 134(2):440-50. PubMed ID: 24506934
[TBL] [Abstract][Full Text] [Related]
17. Integral role of receptor for advanced glycation end products (RAGE) in nondiabetic atherosclerosis.
Uekita H; Ishibashi T; Shiomi M; Koyama H; Ohtsuka S; Yamamoto H; Yamagishi S; Inoue H; Itabe H; Sugimoto K; Kamioka M; Ohkawara H; Wada I; Yasuchika T
Fukushima J Med Sci; 2019; 65(3):109-121. PubMed ID: 31915324
[TBL] [Abstract][Full Text] [Related]
18. Activation of receptor for advanced glycation end products: a mechanism for chronic vascular dysfunction in diabetic vasculopathy and atherosclerosis.
Schmidt AM; Yan SD; Wautier JL; Stern D
Circ Res; 1999 Mar; 84(5):489-97. PubMed ID: 10082470
[TBL] [Abstract][Full Text] [Related]
19. Tempering the wrath of RAGE: an emerging therapeutic strategy against diabetic complications, neurodegeneration, and inflammation.
Yan SF; Yan SD; Ramasamy R; Schmidt AM
Ann Med; 2009; 41(6):408-22. PubMed ID: 19322705
[TBL] [Abstract][Full Text] [Related]
20. Pioglitazone Attenuates Atherosclerosis in Diabetic Mice by Inhibition of Receptor for Advanced Glycation End-Product (RAGE) Signaling.
Gao H; Li H; Li W; Shen X; Di B
Med Sci Monit; 2017 Dec; 23():6121-6131. PubMed ID: 29278639
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
